Clavulanic acid
Clavulanic acid is a naturally occurring compound produced by the bacterium Streptomyces clavuligerus. It functions as a beta-lactamase inhibitor, which means it can inhibit the activity of certain enzymes that can break down beta-lactam antibiotics. This property can be utilized in the development of antibiotic formulations to enhance the effectiveness of beta-lactam antibiotics.
Lab products found in correlation
23 protocols using clavulanic acid
Antimicrobial Resistance Profiling of Carbapenem-Resistant Gram-Negatives
Antibacterial Compound Preparation Protocol
Determining Amoxicillin MIC and MPC in the Presence of Clavulanic Acid
Production and Characterization of Anti-Waddlia Antibodies
Characterizing NaHCO3-responsive MRSA Strains
For penicillin Etest susceptibility testing of penicillin-clavulanate combinations, Iso-Sensitest Agar (ISA, Oxoid) was prepared as per manufacturer’s instructions, with or without 15 μg/mL clavulanic acid (Sigma-Aldrich; see below for further details). For broth MIC testing, RNA isolation/gene expression studies, GFP reporter assays, and Western blotting, strains were cultured in cation-adjusted Mueller-Hinton Broth (CA-MHB, Difco, Beckton-Dickinson) or CA-MHB buffered with 100 mM Tris (CA-MHB Tris) to maintain pH 7.3 ± 0.1, with or without 44 mM NaHCO3. Where indicated, 1/2× MIC of OXA (
Antibiotic Binding Biosensor Assay
Antibiotic Stock Solutions Preparation
Scopolamine-Induced Dementia Model
male Sprague–Dawley (SD) rats that weighed 150–200 g.
Animals were obtained from the pharmacology department of the Zanajn
University of Medical Sciences. Rats were kept in special clear plastic
cages at 23 °C. Adequate water and food were supplied except
during the training. Each animal was used only once and was excluded
from further experimentation under the ethical principles of working
with animals (Ethics Code No. IR.ZUMS.REC.1396.227). Scopolamine has
a role in learning/memory impairments as well as in the induction
of amyloid-beta deposition, synaptic dysfunction, and oxidative stress,
all of which are the most common forms of dementia affecting people
with AD, so it is used to create a laboratory animal model for memory
disorders including AD. Scopolamine hydrobromide was purchased from
Sigma Inc. and diluted according to the manufacturer’s protocol
and used i.p (2 mg/kg). Then, memantine under the brand name Namenda
and clavulanic acid under the brand name potassium clavulanate was
purchased from Sigma Inc. and diluted in normal saline to the recommended
amount of the manufacturer and injected i.p to rats (10 mg/kg). They
were prepared daily to minimize the possibility of any contamination.
Synthesis and Characterization of β-Lactamase Inhibitors
used in this study were obtained from their respective manufacturers
as indicated: ampicillin, cephalothin, and clavulanic acid, potassium
salt, from Sigma (St. Louis, MO); sulbactam, sodium salt, from Pfizer
(Groton, CT); tazobactam, sodium salt, from Chem-IMPEX (Wood Dale,
IL); and nitrocefin from Becton Dickinson (Franklin Lakes, NJ). The
sodium salt of PSR-3-283A (263 Da) and 6-D,D-sulbactam were synthesized
in the laboratory of John D. Buynak. Chemical structures of β-lactamase
inhibitors are represented in Figure
Antimicrobial Combination Evaluation
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!